Business News 25 March 2026 - 7 April 2026

ChampionsGate Stock Little Changed as SPAC Deal Timeline Gets Attention

ChampionsGate Stock Little Changed as SPAC Deal Timeline Gets Attention

ChampionsGate Acquisition Corporation stock was flat in premarket trading Wednesday. The Nasdaq-listed SPAC stayed near the level investors could redeem for cash if the company doesn’t seal a merger. The stock last changed hands at $10.35, off 0.07% in the past 24 hours. TradingView data showed the market shut with no fresh trades on the tape at the time. It had a market cap near $103.4 million.
June 3, 2026
Rolls-Royce Holdings Buyback Rolls On as Fresh Filing Sharpens Focus on £2.5 Billion 2026 Return Plan

Rolls-Royce Holdings Buyback Rolls On as Fresh Filing Sharpens Focus on £2.5 Billion 2026 Return Plan

Rolls-Royce Holdings reported Tuesday it snapped up 385 shares on April 2, paying 1,172.5 pence apiece as part of its £2.3 billion buyback plan running through 2026. The company intends to cancel the shares. The update dropped as London markets reopened following the Good Friday and Easter Monday holidays. Rolls-Royce’s update lands at a time when buybacks have become a linchpin of its pitch to shareholders, following February’s annual results. Back then, the company committed to returning up to £2.5 billion via buybacks in 2026—a chunk of a broader £7 billion-£9 billion program stretching through 2028. The main tranche is scheduled to wrap up by Dec. 23.
April 7, 2026
GSK Shares Slip as U.S.-UK Drug Deal Eases Tariff Threat Before April Results

GSK Shares Slip as U.S.-UK Drug Deal Eases Tariff Threat Before April Results

GSK's U.S. shares slipped roughly 0.7%, closing at $56.29 on Monday, as the market weighed the implications of a freshly completed U.S.-UK medicines agreement for the British pharma giant. This comes on the heels of recent moves around tariffs and drug pricing in the industry. Timing’s key here. GSK, one of the big pharma names protected by tariffs, lands its first-quarter report on April 29—so investors don’t have to wait long to see if that policy buffer is holding up.
April 6, 2026
3i Group Share Price: Why Action’s U.S. Push Has Investors Watching May Results

3i Group Share Price: Why Action’s U.S. Push Has Investors Watching May Results

3i Group managed to rebound ahead of London’s Easter break, ending April 2 up 3.99% at 2,687 pence. With the London Stock Exchange shuttered for Good Friday and Easter Monday, Thursday’s finish remained the reference point for sentiment. Investors are busy rethinking Action’s value ahead of 3i’s annual results on May 14. As of December 31, 3i held a 62.3% stake in Action and reported a diluted net asset value—portfolio value minus liabilities—of 3,017 pence per share. Back in January, Chief Executive Simon Borrows called for another strong year of compounding growth.
April 6, 2026
BHP closes $4.3 billion Antamina silver deal, unlocking cash for copper push

BHP closes $4.3 billion Antamina silver deal, unlocking cash for copper push

BHP Group has wrapped up its $4.3 billion silver streaming agreement with Wheaton Precious Metals, securing instant cash tied to its stake in Peru’s Antamina mine. BHP confirmed receipt of the upfront cash, and Wheaton noted the stream kicked in on April 1. This is relevant now because BHP has leaned on asset-management arrangements to unlock cash, with copper becoming a bigger part of the mix. Back in February, the miner reported copper accounted for 51% of group underlying EBITDA—its preferred gauge of core earnings. The Antamina stream, together with a separate iron ore power agreement in Western Australia, is set to free up more than $6 billion in cash, a figure that could hit $10 billion.
April 2, 2026
GSK plc Completes ViiV Healthcare Shake-Up as Pfizer Exits, Shionogi Lifts Stake

GSK plc Completes ViiV Healthcare Shake-Up as Pfizer Exits, Shionogi Lifts Stake

GSK on Wednesday wrapped up changes to the structure of its HIV unit ViiV Healthcare. Japan’s Shionogi raised its stake to 21.7% as Pfizer exited the partnership entirely. GSK retains a majority holding at 78.3%. Timing is crucial here. HIV remains a cornerstone for GSK, and Chief Executive Luke Miels is gunning for annual sales topping 40 billion pounds by 2031. For 2025, GSK reported HIV sales up 11% to 7.7 billion pounds. Miels is eyeing 2026 as a launch-heavy stretch, promising quicker development cycles and sharper operational focus.
April 1, 2026
British Airways Parent IAG Set for Heathrow Cost Break, but Fuel Shock Still Looms

British Airways Parent IAG Set for Heathrow Cost Break, but Fuel Shock Still Looms

International Consolidated Airlines Group SA may catch a break on costs after Britain’s aviation regulator floated just a modest increase in Heathrow passenger fees for the 2027-2031 period. That’s significant for the owner of British Airways, which is based at Heathrow. The proposal drops a little more than five weeks ahead of IAG’s first-quarter results, set for May 8, and arrives as European airlines face higher fuel costs and network headaches tied to Middle East unrest. For Heathrow, the next price-control period—covering charges from 2027 through 2031—stands out as a major flashpoint on costs for airlines based at the airport.
April 1, 2026
Vodafone Group PLC Accelerates Share Buyback With 5.4 Million Shares Ahead of Year-End

Vodafone Group PLC Accelerates Share Buyback With 5.4 Million Shares Ahead of Year-End

Vodafone Group Plc ramped up its buyback on Tuesday, snapping up 5.4 million ordinary shares from Goldman Sachs International for treasury—part of the February program. That haul was more than twice Monday’s 2.7 million-share disclosure. Vodafone’s timing comes right at the close of its financial year, keeping capital return strategies in the spotlight as shareholders watch for signs that the Three UK merger and ongoing asset disposals will finally stabilize cash flow. Back in February, the company said its 500 million-euro buyback program would wrap up by May 11 at the latest, following 3.5 billion euros of repurchases since May 2024.
March 31, 2026
RELX PLC ramps up share buyback as LexisNexis owner heads into April trading update (Reuters)

RELX PLC ramps up share buyback as LexisNexis owner heads into April trading update (Reuters)

RELX repurchased 3.43 million shares from March 23 through March 27, kicking off the initial week of its latest 350 million pound buyback initiative, according to a company filing. The shares, bought at the reported prices, came to roughly 83.5 million pounds and will be held in treasury instead of being released immediately to the market. This is notable, with the LexisNexis parent only a few weeks into a pledged £2.25 billion buyback program slated for 2026—a hefty payout as shareholders weigh just how resilient growth will be in legal, risk, and science information, especially as AI tools roll out. RELX claims the very tech shaking up the industry can actually make its own offerings more valuable to customers.
March 31, 2026
3i Group insiders buy £9.5 million of shares after Action selloff

3i Group insiders buy £9.5 million of shares after Action selloff

3i Group reported new insider buying Tuesday: Head of Private Equity Peter Wirtz picked up 25,000 shares, following Chief Executive Simon Borrows and family trusts, who grabbed 350,147 shares just a day earlier. Together, the two filings represent roughly £9.5 million in stock snagged after last week’s selloff in the London-listed investment group. 3i’s shares plunged 17.6% on March 26, hitting their lowest point in over two years, after the company said its Dutch discount chain Action is targeting like-for-like sales growth of just 4% to 5% in 2026. The retailer also mapped out plans to launch its first U.S. store before the end of 2027 or in early 2028. Action’s CEO, Hajir Hajji, told investors the business is “strong
March 31, 2026
BlackRock Weighs HSBC’s Canary Wharf Tower for London HQ as 2027 Exit Nears

BlackRock Weighs HSBC’s Canary Wharf Tower for London HQ as 2027 Exit Nears

BlackRock is considering taking over HSBC Holdings Plc's Canary Wharf tower for its next London headquarters, according to a Tuesday story in the Financial Times. The asset manager wouldn’t comment, and Reuters said it couldn’t confirm the report on its own. HSBC’s move to leave 8 Canada Square would put one of the city’s largest post-pandemic office vacancies on the market. This comes during a squeeze in high-end office supply, with rents climbing and companies pushing employees to return to their desks.
March 31, 2026
3i Group CEO Buys £9 Million of Stock After Action Slowdown Triggers Selloff

3i Group CEO Buys £9 Million of Stock After Action Slowdown Triggers Selloff

Simon Borrows, chief executive of 3i Group, snapped up almost £9 million worth of shares following last week’s sharp decline in the FTSE 100 investment company. According to a regulatory filing released Monday, Borrows and family trusts tied to him acquired 350,147 shares at £25.55 apiece on March 26. This shift carries weight since 3i’s stock tracks closely with Action, the Dutch discount retailer that dominates its portfolio. Shares slumped 17.66% on Thursday, triggered by Action’s latest figures: like-for-like sales up just 4.0% for the first 12 weeks of 2026. Full-year guidance? No change.
March 30, 2026
Rolls-Royce Holdings buys back 2.25 million shares as oil shock clouds airline outlook

Rolls-Royce Holdings buys back 2.25 million shares as oil shock clouds airline outlook

LONDON, March 30, 2026, 13:16 BST. Rolls-Royce Holdings reported Monday it snapped up roughly 2.25 million shares for cancellation, part of its ongoing £2.3 billion buyback slated to run through 2026. Despite oil prices climbing and sparking new worries about airline appetite, the company is pushing ahead with cash returns. Rolls-Royce said the transactions took place March 27 across four venues, including the London Stock Exchange.
March 30, 2026
4DMedical Ltd Wins EU CE Mark, Raises A$83 Million as Mayo Clinic Deal Boosts CT:VQ Push

4DMedical Ltd Wins EU CE Mark, Raises A$83 Million as Mayo Clinic Deal Boosts CT:VQ Push

4DMedical disclosed in a Friday filing that its CT:VQ technology secured European Union CE mark certification. The Australian medtech also said it had raised A$83 million from institutional investors, a boost to fund its European ambitions. Shares ended the day at A$6.28, having hit A$7.55 earlier in the session. The timing comes into play as 4DMedical looks to build on recent U.S. hospital contracts and push for wider commercial uptake. According to the company, CT:VQ assesses how air and blood flow throughout the lungs using regular non-contrast CT scans—skipping the radiotracers needed for classic nuclear V/Q imaging.
March 29, 2026
Meituan Stock Faces New Test After 2025 Loss as China Delivery Price War Hits Margins

Meituan Stock Faces New Test After 2025 Loss as China Delivery Price War Hits Margins

Meituan opened the week with its Hong Kong-listed stock on trader watch, after the company revealed a 23.35 billion yuan loss for 2025—subsidy-driven, and hard to ignore. The shares settled Friday at HK$85.90, a 0.9% dip. For much of last week, investors chewed over the earnings blow, even as talk of a possible regulatory easing started to trickle out. Timing couldn’t have been sharper: just as Beijing and state outlets flagged a crackdown on the food-delivery price war, the numbers landed. Reuters reports state media called for an end to the bruising, profit-sapping fight for market share, and China’s market regulator backed them up by sharing the article—traders took that as a cue. That alone pushed Meituan, Alibaba, and JD.com
March 29, 2026
Tencent Stock News: Fresh Buyback Filing Lands as AI Push Tests 0700.HK

Tencent Stock News: Fresh Buyback Filing Lands as AI Push Tests 0700.HK

Tencent Holdings stepped in again toward last week's close, snapping up 610,000 shares on March 27 for a total of HK$300.7 million. The company paid between HK$488 and HK$498 per share, according to a Hong Kong filing. These shares will be cancelled. The day before, a filing disclosed Tencent had bought back 590,000 shares, spending HK$294.9 million. These consecutive repurchases stand out—they landed just days after Tencent warned investors that 2026 buybacks would lag last year’s, citing higher spending on artificial intelligence.
March 29, 2026
Haleon PLC Stock Price Today: Q1 Memo Keeps 2026 Growth Questions Alive

Haleon PLC Stock Price Today: Q1 Memo Keeps 2026 Growth Questions Alive

Haleon traded flat on Friday, hovering around 366 pence. The company dropped a brief pre-results aide memoire—essentially a heads-up for analysts—ahead of its Q1 trading update set for April 29. It’s important here because Haleon is still working to reassure investors after last month’s call for 2026 organic revenue growth at 3% to 5%, missing the company’s medium-term target of 4% to 6%. Organic revenue figures, which ignore currency moves and recent acquisitions, rattled the market—shares dropped as much as 6% after that February guidance.
March 27, 2026
International Consolidated Airlines Group (IAG) Share Price Slips Even After 115 Million Share Cancellation

International Consolidated Airlines Group (IAG) Share Price Slips Even After 115 Million Share Cancellation

International Consolidated Airlines Group—parent of British Airways—slipped about 2% to 359 pence on Thursday. The decline came despite news of a capital reduction through the cancellation of 115.5 million treasury shares. At Thursday’s close, the stock traded roughly 23% under its 52-week peak from Feb. 27. This filing is significant—it cancels shares acquired during a €1 billion buyback wrapped up in November, pushing forward IAG’s push to return cash to investors. That push got fresh fuel on Feb. 26, when a new €500 million repurchase kicked off, again aiming specifically to cut share capital.
March 26, 2026
Unilever Stock Price Hovers Near 1-Year Low as McCormick Foods Deal Doubts Persist

Unilever Stock Price Hovers Near 1-Year Low as McCormick Foods Deal Doubts Persist

Unilever hovered just above its lowest mark in a year Thursday, slipping 0.4% to 4,504 pence by the close of late London trading. The stock touched 4,481 pence on Wednesday, the weakest level in twelve months, according to FT market data. Not much wiggle room here. Fernando Fernandez, aiming to prove Unilever’s stripped-down profile can actually pick up the pace post-Magnum ice cream spinoff, still has a tough sell: back in February, the company projected 2026 growth scraping the lower bound of its 4%-6% target—despite delivering a 20% operating margin in 2025 and announcing a fresh 1.5 billion euro share buyback.
March 26, 2026
Legal & General Share Price Rises After Manulife Partnership as Investors Reassess Growth Plan

Legal & General Share Price Rises After Manulife Partnership as Investors Reassess Growth Plan

Legal & General shares climbed Wednesday, after the British insurer and asset manager announced a strategic partnership with Manulife Wealth & Asset Management the previous day. The stock traded at 243.5 pence as of 13:15 GMT, showing a gain of roughly 1.8% from Tuesday's 239.3p close, according to company and exchange data. This latest deal lands as L&G keeps working to regain investor trust after missing key metrics in its March 11 results and revealing a softer solvency cushion—even with that record £1.2 billion buyback. Chief Executive Antonio Simoes claimed earlier this month, “in two years, we’ve reshaped the company.” Still, the stock has mostly drifted sideways since Simoes stepped in at the start of 2024. Over the same stretch,
March 25, 2026
1 6 7 8 9 10 18